OnKure Therapeutics, Inc.
OKUR
$3.84
-$0.07-1.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 14.69M | 15.40M | 13.21M | 13.09M | 10.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 62.95M | 66.68M | 62.69M | 60.09M | 52.92M |
| Operating Income | -62.95M | -66.68M | -62.69M | -60.09M | -52.92M |
| Income Before Tax | -59.52M | -63.46M | -60.31M | -59.06M | -52.67M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -59.52 | -63.46 | -60.31 | -59.06 | -52.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -59.52M | -63.46M | -60.31M | -59.06M | -52.67M |
| EBIT | -62.95M | -66.68M | -62.69M | -60.09M | -52.92M |
| EBITDA | -62.50M | -66.22M | -62.22M | -59.62M | -52.46M |
| EPS Basic | -4.40 | -4.78 | -40.24 | -83.92 | -113.10 |
| Normalized Basic EPS | -2.75 | -2.94 | -25.11 | -51.17 | -69.41 |
| EPS Diluted | -4.40 | -4.78 | -40.24 | -83.92 | -113.10 |
| Normalized Diluted EPS | -2.75 | -2.94 | -25.11 | -51.17 | -69.41 |
| Average Basic Shares Outstanding | 54.06M | 53.24M | 40.02M | 26.83M | 13.72M |
| Average Diluted Shares Outstanding | 54.06M | 53.24M | 40.02M | 26.83M | 13.72M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |